Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,679 | N/A | N/A | 18,850 | N/A |
| Marketable Securities | 67,826 | N/A | N/A | 20,004 | N/A |
| TOTAL | $122,885 | $N/A | $N/A | $46,155 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,953 | 0 | 0 | 2,234 | 0 |
| TOTAL | $1,953 | $N/A | $N/A | $2,234 | $N/A |
| Total Assets | $124,838 | $N/A | $N/A | $48,389 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,945 | 0 | 0 | 8,793 | 0 |
| Accrued Expenses | 18,177 | N/A | N/A | 4,950 | N/A |
| TOTAL | $20,502 | $N/A | $N/A | $14,099 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,396 | 0 | 0 | 1,683 | 0 |
| TOTAL | $1,396 | $N/A | $N/A | $1,683 | $N/A |
| Total Liabilities | $21,898 | $N/A | $N/A | $15,782 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,488 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | N/A | 1 | N/A |
| Retained earnings | -137,042 | N/A | N/A | -66,770 | N/A |
| Other shareholders' equity | -94 | 0 | 0 | -2 | 0 |
| TOTAL | $102,940 | $N/A | $N/A | $32,607 | $N/A |
| Total Liabilities And Equity | $124,838 | $0 | $0 | $48,389 | $0 |